Skip to main content

Table 1 Summary of genome-wide significant genetic instruments of sleep traits in the discovery genome-wide association studies

From: Investigating the causal interplay between sleep traits and risk of acute myocardial infarction: a Mendelian randomization study

Sleep traits

Discovery GWAS

PMID

N

Cohorts used by the discovery GWAS

No. of SNPs identified

UKBB

23andMe

Insomnia symptoms

Jansen et al., 2019 [30]

30804565

1 331 010

109 402 cases and 277 131 controls

288 557 cases and 655 920 controls

248

24-hour sleep duration (h)

Dashti et al., 2019 [31]

30846698

446 118

446 118 samples

Not included

78

Short sleep (≤ 6 h vs. 7–8 h)

Dashti et al., 2019 [31]

30846698

411 934

106 192 cases and 305 742 controls

Not included

27

Long sleep (≥ 9 h vs. 7–8 h)

Dashti et al., 2019 [31]

30846698

339 926

34 184 cases and 305 742 controls

Not included

8

Chronotype (morning preference)*

Jones et al., 2019 [32]

30696823

651 295

252 287 cases and 150 908 controls

120 478 cases and 127 622 controls

351

  1. GWAS indicated genome-wide association studies, N sample size, SNPs single nucleotide polymorphisms, UKBB UK Biobank
  2. *In the discovery GWAS of chronotype, the chronotype increasing allele is morning preference